Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dolores Grosso

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Seminars in Oncology|December 5, 2012
A two-step approach to allogeneic haploidentical hematopoietic stem cell transplantationDolores Grosso, Neal Flomenberg
Transplantation and Cellular Therapy|July 26, 2021
Second Transplant for Relapsed AML, Learning from DefeatUsama Gergis, Dolores Grosso
Cancer|January 3, 2014
Posttreatment interleukin-2 in patients with acute myeloid leukemia: the end of a long road for patients and clinical trials?Dolores Grosso, Mark A Weiss
The Journal of Nursing Education|November 9, 2010
Doctor of nursing practice students advocating for health care access, quality, and reform: from the virtual classroom to Capitol HillMary Lou Manning, Dolores Grosso
Discovery Medicine|October 9, 2013
Recent advances in haploidentical stem cell transplantationOnder Alpdogan, Dolores Grosso, Neal Flomenberg
Frontiers in Immunology|September 18, 2023
The two-step approach to allogeneic hematopoietic stem cell transplantationSikemi Ibikunle, Dolores Grosso, Usama Gergis
Nature Communications|October 28, 2016
Evaluating frequency and quality of pathogen-specific T cellsNadia Anikeeva, Dolores Grosso, Neal Flomenberg, et al.
Case Reports in Oncology|September 5, 2017
Relapsed Multiple Myeloma Presenting as Intracranial Plasmacytoma and Malignant Pericardial Effusion following Recent Allogeneic Stem Cell TransplantationJonathan Pan, Jason Chen, Joanne Filicko, et al.
Frontiers in Oncology|October 15, 2019
The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell TransplantationDolores Grosso, Benjamin Leiby, Matthew Carabasi, et al.
Hematology/Oncology and Stem Cell Therapy|May 22, 2026
The Two-Step Allogeneic Stem Cell Transplant Is Associated with Excellent Engraftment, Improved Survival and Low Nonrelapse Mortality in Patients with MyelofibrosisXia Bi, Shaik Rashid, Joanne Filicko-O'Hara, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Seminars in Oncology|December 5, 2012
A two-step approach to allogeneic haploidentical hematopoietic stem cell transplantationDolores Grosso, Neal Flomenberg
Transplantation and Cellular Therapy|July 26, 2021
Second Transplant for Relapsed AML, Learning from DefeatUsama Gergis, Dolores Grosso
Cancer|January 3, 2014
Posttreatment interleukin-2 in patients with acute myeloid leukemia: the end of a long road for patients and clinical trials?Dolores Grosso, Mark A Weiss
The Journal of Nursing Education|November 9, 2010
Doctor of nursing practice students advocating for health care access, quality, and reform: from the virtual classroom to Capitol HillMary Lou Manning, Dolores Grosso
Discovery Medicine|October 9, 2013
Recent advances in haploidentical stem cell transplantationOnder Alpdogan, Dolores Grosso, Neal Flomenberg
Frontiers in Immunology|September 18, 2023
The two-step approach to allogeneic hematopoietic stem cell transplantationSikemi Ibikunle, Dolores Grosso, Usama Gergis
Nature Communications|October 28, 2016
Evaluating frequency and quality of pathogen-specific T cellsNadia Anikeeva, Dolores Grosso, Neal Flomenberg, et al.
Case Reports in Oncology|September 5, 2017
Relapsed Multiple Myeloma Presenting as Intracranial Plasmacytoma and Malignant Pericardial Effusion following Recent Allogeneic Stem Cell TransplantationJonathan Pan, Jason Chen, Joanne Filicko, et al.
Frontiers in Oncology|October 15, 2019
The Presence of a CMV Immunodominant Allele in the Recipient Is Associated With Increased Survival in CMV Positive Patients Undergoing Haploidentical Hematopoietic Stem Cell TransplantationDolores Grosso, Benjamin Leiby, Matthew Carabasi, et al.
Hematology/Oncology and Stem Cell Therapy|May 22, 2026
The Two-Step Allogeneic Stem Cell Transplant Is Associated with Excellent Engraftment, Improved Survival and Low Nonrelapse Mortality in Patients with MyelofibrosisXia Bi, Shaik Rashid, Joanne Filicko-O'Hara, et al.
Pageof 3